These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8823977)

  • 1. Cisatracurium: a new nondepolarizing neuromuscular blocking agent.
    Owens CA; Brakoniecki J
    Conn Med; 1996 Aug; 60(8):461-3. PubMed ID: 8823977
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rocuronium and cisatracurium.
    Pollard BJ
    Br J Hosp Med; 1997 Apr 2-15; 57(7):346-8. PubMed ID: 9217862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential neuroprotective properties of atracurium and cisatracurium in neurosurgical anaesthesia.
    Fodale V; Praticò C; Santamaria LB
    Eur J Anaesthesiol; 2004 Apr; 21(4):333-4; author reply 334-5. PubMed ID: 15109204
    [No Abstract]   [Full Text] [Related]  

  • 5. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cisatracurium in critical care: a review of the literature.
    Szakmany T; Woodhouse T
    Minerva Anestesiol; 2015 Apr; 81(4):450-60. PubMed ID: 24721895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review.
    Reeves ST; Turcasso NM
    South Med J; 1997 Aug; 90(8):769-74. PubMed ID: 9258301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postsynaptic nondepolarizing muscle relaxants in clinical practice].
    Danilov AF
    Eksp Klin Farmakol; 1998; 61(3):74-80. PubMed ID: 9690085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery properties of cisatracurium and vecuronium in intensive care unit patients.
    Fuchs-Buder T; Suter PM
    Anesth Analg; 1996 Apr; 82(4):892-3. PubMed ID: 8615532
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of nondepolarizing myorelaxants in neonates].
    Shabanova SK; Mikhel'son VA; Zhirkova IuV; Agavelian EG; Shaginian AK; Sepbaeva AD
    Anesteziol Reanimatol; 2008; (1):26-9. PubMed ID: 18368836
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(5):899-904. PubMed ID: 8888085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Muscle relaxation in Emery-Dreifuss muscular dystrophy].
    Moncho JM; Roigé J; Nadal M; Saludes J; Cabarrocas E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):403. PubMed ID: 8584784
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisatracurium, but not mivacurium, induces apoptosis in human umbilical vein endothelial cells in vitro.
    Rieder J; Lirk P; Bodrogi F; Sawires M; Gruber G; Hoffmann G
    Eur J Anaesthesiol; 2005 Jan; 22(1):16-9. PubMed ID: 15816567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats.
    Nguyen A; Ramzan I
    Pharmazie; 2000 Dec; 55(12):957. PubMed ID: 11189879
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of atracurium, cisatracurium, and mivacurium on the proliferation of two human cell lines in vitro.
    Amann A; Rieder J; Fleischer M; Niedermüller P; Hoffmann G; Amberger A; Marth C; Nigrovic V; Pühringer F
    Anesth Analg; 2001 Sep; 93(3):690-6. PubMed ID: 11524342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisatracurium besylate--Nimbex].
    Jensen FS; Mogensen JV
    Ugeskr Laeger; 1998 Feb; 160(6):858-60. PubMed ID: 9469987
    [No Abstract]   [Full Text] [Related]  

  • 19. The onset time of atracurium is prolonged in patients with sickle cell disease.
    Dulvadestin P; Gilton A; Hernigou P; Marty J
    Anesth Analg; 2008 Jul; 107(1):113-6. PubMed ID: 18635475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of congenital endplate acetylcholinesterase deficiency by neuromuscular blockade.
    Breningstall GN; Kurachek SC; Fugate JH; Engel AG
    J Child Neurol; 1996 Jul; 11(4):345-6. PubMed ID: 8807428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.